FDMT Financials
4D Molecular Therapeutics Inc - Financial statements & key metrics
Stock Price
$8.46
Market Cap
$483.36M
EPS
$-3.75
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$37,000
Gross Profit
-
Operating Income
-
Net Income
$-160.87M
EPS (Diluted)
$-2.98
Balance Sheet Highlights
Total Assets
$560.38M
Total Liabilities
$49.78M
Shareholders Equity
-
Cash & Equivalents
$149.34M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-134.59M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-148295.8%
Operating Margin
-655.4%
ROE
-0.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is FDMT revenue?
FDMT's most recent quarterly revenue was $37,000. Annual revenue can be calculated by summing the four most recent quarters.
Is FDMT profitable?
FDMT reported a loss of $160.87M in the most recent quarter.
What is FDMT market cap?
FDMT has a market capitalization of $483.36M, making it a small-cap stock.
Does FDMT have debt?
View FDMT's balance sheet for debt information.
What is FDMT cash flow?
Cash flow data is available in the full financial statements.